Nextgen Stock Fundamentals
| NXGN Stock | ILS 65.00 5.00 8.33% |
Nextgen fundamentals help investors to digest information that contributes to Nextgen's financial success or failures. It also enables traders to predict the movement of Nextgen Stock. The fundamental analysis module provides a way to measure Nextgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nextgen stock.
Nextgen |
Nextgen Company Return On Equity Analysis
Nextgen's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nextgen Return On Equity | -0.52 |
Most of Nextgen's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nextgen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nextgen has a Return On Equity of -0.5221. This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all Israel stocks is notably higher than that of the company.
Nextgen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nextgen's current stock value. Our valuation model uses many indicators to compare Nextgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nextgen competition to find correlations between indicators driving Nextgen's intrinsic value. More Info.Nextgen is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nextgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nextgen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nextgen Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nextgen's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nextgen could also be used in its relative valuation, which is a method of valuing Nextgen by comparing valuation metrics of similar companies.Nextgen is currently under evaluation in return on equity category among its peers.
Nextgen Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.12 | |||
| Current Valuation | 22.16 M | |||
| Shares Outstanding | 39.68 M | |||
| Shares Owned By Insiders | 11.91 % | |||
| Price To Book | 1.51 X | |||
| EBITDA | (2.53 M) | |||
| Net Income | (2.55 M) | |||
| Cash And Equivalents | 6.34 M | |||
| Cash Per Share | 0.28 X | |||
| Current Ratio | 7.37 X | |||
| Book Value Per Share | 0.28 X | |||
| Cash Flow From Operations | (2.66 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 15 | |||
| Beta | 1.1 | |||
| Market Capitalization | 26.86 M | |||
| Total Asset | 23.63 M | |||
| Net Asset | 23.63 M |
About Nextgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nextgen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nextgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nextgen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nextgen Biomed Ltd, through its subsidiary, develops medicines for the treatment of psoriasis.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nextgen Stock
Nextgen financial ratios help investors to determine whether Nextgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nextgen with respect to the benefits of owning Nextgen security.